From January 29 to February 4, President of Beroni USA Mr. Linfeng Li came to Guang Zhou with “Virus Hunter” Professor Walter Ian Lipkin, helping prevent and control COVID-19 outbreak.
On January 30, Beroni Group called on all employees to make preparations for virus prevention and control.
In February, Beroni Group initiated a donation event to help contain the pandemic with people who are fighting against the COVID-19.
In February, H.E. Yukio Hatoyama, Former Prime Minister of Japan sent a video in which he expressed encouragement and confidence to Chinese people in the war of fighting against the pandemic.
On March 25, Beroni Group’s SARS-CoV-2 IgG/IgM Antibody Detection Kit received the acknowledgment letter of Emergency Use Authorization from FDA.
In April, the SARS-CoV-2 IgG/IgM Antibody Detection Kit of Beroni Group received CE certification.
In May, Beroni China (Tianjin Beroni Biotechnology Co., Ltd.) was included in the List of Medical Devices and Supplies Companies with Certification/Authorization from Other Countries and its SARS-CoV-2 IgG/IgM Antibody Detection Kit was included in product list of China Chamber of Commerce of Medicines & Health Products Importers & Exporters.
On May 11, Beroni Group’s development of a medical solution for SARS-CoV-2, in collaboration with Tianjin University, has made a significant discovery of 24 types of nanobodies with high affinity to SARS-CoV-2 antigens, which has been highlighted in several online media sites.
On May 13, Beroni Group and Beijing Health Industrial Investment Management Co., Ltd. signed a strategic cooperation agreement to collaborate in fields of medical treatment, health care and aged care.
On May 22, representatives of Huarong Securities Co., Ltd. visited Beroni China and had a cordial talk with Mr. Jacky Zhang, Executive Chairman of Beroni Group on health industry projects and financial investment and financing.
On June 12, Beroni Group was invited to attend “The SIFIA and Embassy of the Federal Democratic Republic of Ethiopia in China Project Exchange Conference”.
On July 8, Beroni Group and Henan Linfeng Education Foundation signed a strategic agreement to cooperate in scientific research, achievement transformation, talents training and practicing fields in future.
On August 12, Beroni Group signed an agreement with GenScript Biotech Corporation to collaborate in the development of a medical solution utilizing nanobody technology for COVID-19, especially in conducting pseudovirus neutralization test, humanization and affinity maturation of nanobodies.
On August 20, Mr. Yang Li, Section Chief of Xiqing Science and Technology Commission and other accompanies came to Beroni China to learn about the status of “Xiqing Scientific and Technological Breakthrough & Transformation and Industrialization of Scientific Achievements Project”.
From September 4 to 6, Beroni Group organized an outdoor activity at Beijing Shidu Scenic Spot.
In mid-September, Beroni Group successfully held “2020 Outbound Activity Photo Contest”.
On September 16, Mr. Jacky Zhang’s classmates from class E-19C of Tsinghua SEM and members in Tsinghua Alumni Association of Tianjin visited Beroni China.
In September, Beroni Group bought many daily supplies and Mid-Autumn Festival gifts for children in Beroni Yongnian Love School and raised a donation to help them continue to learn in school.
In October, Beroni Group’s CII-ArboViroPlex rRT-PCR Test won honors in “Maker in China” competition, including top 50 in the Enterprise Group of the competition and top 100 in Enterprise Group of the competition.
On October 19, representatives of Beijing Higginger Pharmaceuticals Co., Ltd. came to visit Beroni China. Two sides had a talk on Beroni Group’s core projects: anti-cancer drug PENAO, Arbo ViroPlex rRT-PCR test kit, SARS-CoV-2 IgG/IgM Antibody Detection Kit.
On October 19, Beroni Group successfully completed the SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation.
On November 9, Beroni Group was recognized as one of the top infection control solutions companies in APAC for 2020 by MedTech Outlook.
On November 10, Beroni Group launched a new product “Beilemei” in China, which is a probiotics health product aimed at modulating the balance of human intestinal flora.
On December 12, Mr. Jacky Zhang, Executive Chairman of Beroni Group was invited to attend The 2nd China Health Industry Conference.
On December 14, Beroni Group successfully held its Press Conference for Planing to Conduct International Projects in the Guangdong-Hong Kong-Macau Greater Bay Area.
On December 21, Beroni Group announced that its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) complies with the applicable essential requirements of the European Parliament and of the Council’s directive 98/79/EEC on in vitro diagnostics as amended, and has received CE certification.
On December 25, Beroni Group donated warm clothes to the poor in Dege county of Tibetan Autonomous Prefecture of Garzê, Sichuan province.
